CIK 0001971532 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in FL · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -10.4 M | -13.1 M | -854147 |
| Diluted EPS (USD/shares) | -0.33 | 0.48 | -0.03 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 8-K | 8-K items 1.01,3.02,7.01,9.01 | 2026-10-05 |
| 2026-09-17 | 8-K | 8-K items 7.01,9.01 | 2026-09-17 |
| 2026-09-16 | 8-K | 8-K items 5.07,9.01 | 2026-09-11 |
| 2026-09-14 | 8-K | 8-K items 7.01,9.01 | 2026-09-14 |
| 2026-08-19 | DEFA14A | DEFA14A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-10 | 8-K | 8-K items 7.01,9.01 | 2026-08-10 |
| 2026-07-28 | DEF 14A | DEF 14A | 2026-07-28 |
| 2026-07-27 | 4 | 4 | 2026-04-16 |
| 2026-07-27 | 4 | 4 | 2026-04-16 |
| 2026-07-27 | 4 | 4 | 2026-04-16 |
| 2026-06-15 | 8-K | 8-K items 7.01,9.01 | 2026-06-15 |
| 2026-06-09 | 3 | 3 | 2026-06-03 |
| 2026-06-08 | 8-K | 8-K items 5.02,9.01 | 2026-06-03 |
| 2026-05-22 | 4 | 4 | 2026-05-21 |
| 2026-05-22 | 4 | 4 | 2026-05-21 |
| 2026-05-22 | 4 | 4 | 2026-05-21 |
| 2026-05-22 | 4 | 4 | 2026-05-21 |
| 2026-05-20 | 8-K | 8-K items 7.01,9.01 | 2026-05-20 |
| 2026-05-14 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-30 | 8-K | 8-K items 8.01 | 2026-04-24 |
| 2026-04-24 | 4 | 4 | 2026-04-22 |
| 2026-04-24 | 8-K | 8-K items 1.01,2.01,3.02,9.01 | 2026-04-22 |
| 2026-03-31 | 8-K | 8-K items 8.01 | 2026-03-30 |
Forms on file (last 1,000): 8-K 63, 3 17, 4 17, 10-Q 8, CORRESP 6, UPLOAD 5, 10-K 3, PRER14A 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TELO (0.002 USD), /gw/filings/filings?ticker=TELO&form=8-K, /gw/filings/facts?ticker=TELO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange